IDENTIFICATION OF A NOVEL N-TERMINAL DOMAIN NUCLEOCAPSID OF SARS-COV-2 INHIBITORS USING IN SILICO VIRTUAL SCREENING

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. Protein-targeted therapeutics are currently unavailable for this virus. In this research, we apply a molecular docking approach to identify inhibitors of the N protein that can be used as antiviral medications. This work summarizes the v...

Descripció completa

Dades bibliogràfiques

Autors principals:	Derouicha MATMOUR, Mimouna BEKKADOUR, Dalila MIRAOUI, Nezha SEKKAL, Saliha BENABDI, Ahmed Oughilas, Chahrazed KANDOUCI, Yassine MERAD
Format:	Artigo
Idioma:	Inglês
Publicat:	Assiut University, Faculty of Pharmacy 2025-12-01
Col·lecció:	Bulletin of Pharmaceutical Sciences. Assiut University
Matèries:	SARS-CoV-2 Nucleocapsid protein N-terminal domain Molecular docking Druglikness
Accés en línia:	https://bpsa.journals.ekb.eg/article_424729_9d05a89143d4b7b9d680082620a3a297.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!